From: Kramer, Mark
Sent: Tuesday, November 12, 2002 8:39 AM
To: Dockets, FDA
Subject: FW: FDA Regulation of Combination Products [Docket No.
02N-0445]

Registration for 02N-0445

-----Original Message-----
From: 	Loretta.Robertson@altanapharma-us.com [mailto:Loretta.Robertson@altanapharma-us.com] 
Sent:	Friday, November 08, 2002 6:11 PM
To:	mkramer@oc.fda.gov
Subject:	FDA Regulation of Combination Products [Docket No. 02N-0445]

Dear Mark,

As we discussed on the phone yesterday, Altana Pharma plans to be a non-presenting participant in the November 25th Public Hearing regarding FDA Regulation of Combination Products [Docket No. 02N-0445].  I expect that we will have one to two attendees.  Also, as we discussed, please send information regarding the potential for dial-in access to the hearing.
Thank you again for your kind assistance with my questions about the meeting.  I look forward to hearing from you.

Best Regards,
Loretta

-------------------------------------------------------------------------------
Dr. Loretta A. Robertson
Senior Regulatory Affairs Specialist

ALTANA Pharma
210 Park Avenue
Florham Park, NJ 07932
USA

Tel:  +1 (973) 514-4272
Fax:  +1 (973) 236-9672
E-mail:  Loretta.Robertson@Altanapharma-us.com